About
Browse articles
For contributors
- The role of fecal calprotectin in pediatric disease
- Su Jin Jeong
- Clin Exp Pediatr. 2019;62(8):287-291.
- Reality of Kawasaki disease epidemiology
- Gi Beom Kim
- Clin Exp Pediatr. 2019;62(8):292-296.
- Can iron be a risk factor for coronary lesions in Kawasaki disease?
- Kyung Lim Yoon
- Clin Exp Pediatr. 2019;62(8):297-298.
- Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
- Gwang Cheon Jang
- Clin Exp Pediatr. 2019;62(8):299-300.
- Iron deficiency anemia as a predictor of coronary artery abnormalities in Kawasaki disease
- Sohyun Kim, Lucy Youngmin Eun
- Clin Exp Pediatr. 2019;62(8):301-306.
- The relation between serum levels of epidermal growth factor and necrotizing enterocolitis in preterm neonates
- Heba Mostafa Ahmed, Nsreen Mostafa Kamel
- Clin Exp Pediatr. 2019;62(8):307-311.
- Evaluation of hematologic profile may be needed for patients treated with oxcarbazepine
- Gu Hyun Jung, Su Jeong You
- Clin Exp Pediatr. 2019;62(8):312-316.
